FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ondansetron Hydrochloride Injection
Status: Currently in Shortage
»Date first posted: 04/11/2018
»Therapeutic Categories: Gastroenterology

Expand all

Apotex Corp. (Reverified 10/30/2019)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ondansetron 2mg/mL 2mL vials Box of 25 vials (NDC 60505-6130-05) Available Available

AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.) (Revised 10/07/2019)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 2 mL vial, 25 count (NDC 55150-125-02) Currently on backorder, next shipment expected Dec. 2019 Intermittent availability expected Demand increase for the drug
2 mg/mL, 20 mL vial, 1 count (NDC 55150-126-20) Currently on backorder, next shipment expected Dec. 2019 Intermittent availability expected Demand increase for the drug

Baxter Healthcare (Reverified 09/05/2019)

Company Contact Information:
800-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ondansetron Injection, USP (2 mg/mL) 2 mL Single Use Glass Vial (25 x 2 mL) (NDC 36000-012-25) Available For IV or IM injection

Fresenius Kabi USA, LLC (Revised 11/12/2019)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02) Available Check wholesalers for inventory Demand increase for the drug
Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20) Backordered. Next release December 2019. Demand increase for the drug
Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20) Available Check wholesalers for inventory Demand increase for the drug

Gland Pharma (Reverified 10/28/2019)

Company Contact Information:
609-250-7990

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL 2mL vial (NDC 70860-776-02) Available Marketed by Athenex. To order, contact Athenex at 855-273-0154 Available
2 mg/mL 20mL vial (NDC 70860-777-20) Available Marketed by Athenex. To order, contact Athenex at 855-273-0154 Available
2 mg/mL, 2 mL vial (NDC 72266-123-25) Available Distributed by Fosun Pharma USA Inc. Company Contact Information: 833-291-9645 Available
2 mg/mL, 20 mL vial (NDC 72266-124-01) Available Distributed by Fosun Pharma USA Inc. Company Contact Information: 833-291-9645 Available

Heritage Pharma (Reverified 08/01/2018)

Company Contact Information:
866-901-1230

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Inj4mg/2mL, 25 (NDC 23155-549-31) Limited supply available Demand increase for the drug
PPRx4mg/2mL (NDC 23155-548-41) Limited supply available Demand increase for the drug
PPRx4mg/2mL (NDC 23155-548-42) Limited supply available Demand increase for the drug
4mg/2mL, 10 (NDC 23155-547-41 ) Limited supply available Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 10/09/2019)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mg/mL, 2 mL vial (NDC 0641-6078-25) Inventory is currently available Additional lots are scheduled for manufacturing in the October – November 2019 timeframe. Product will be made available as it is released. Demand increase for the drug
2 mg/mL, 20 mL vial (NDC 0143-9890-01) Inventory is currently available. Additional lots are scheduled for manufacturing in the October – November 2019 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Reverified 11/08/2019)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mg/2 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-4755-03) Available Other
4 mg/2 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1120-12) Next Delivery and Estimated Recovery: August 2020 Shortage per Manufacturer: Manufacturing Delay Other
40 mg/20 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-4759-01) Next Delivery and Estimated Recovery: December 2019 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other

Sagent Pharmaceuticals (Reverified 11/15/2019)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40mg/20mL EA 1 Vial (NDC 25021-782-20) Available
4mg/2mL PK 25 Vials (NDC 25021-777-02) Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English